PRELIMINARY REPORT ON THE TREATMENT OF MENTALLY DISORDERED PATIENTS BY INTRATHECALLY ADMINISTERED PHENOTHIAZINE DRUGS AND AN ANTISEROTONIN SUBSTANCE.
D001007:Anxiety; D001008:Anxiety Disorders; D001714:Bipolar Disorder; D002389:Catatonia; D004876:Ergot Alkaloids; D007278:Injections, Spinal; D001523:Mental Disorders; D008784:Methysergide; D009497:Neurotic Disorders; D009966:Orphenadrine; D012559:Schizophrenia; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014268:Trifluoperazine
D004876:Ergot Alkaloids; D008784:Methysergide; D009966:Orphenadrine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014268:Trifluoperazine
CATATONIA; ERGOT ALKALOIDS; INJECTIONS, INTRATHECAL; METHYSERGIDE; NEUROSES, ANXIETY; ORPHENADRINE; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; SEROTONIN INHIBITORS; TRIFLUOPERAZINE